Results 151 to 160 of about 39,365 (191)

Real-world observational study of infections in people treated with ocrelizumab for multiple sclerosis. [PDF]

J Neurol
Davies L, Shehadeh R, Watkins WJ, Jolles S, Robertson NP, Tallantyre EC.   +5 more
europepmc   +1 more source

Immunization and cardiovascular disease in Latin America. The CorVacc study: rationale and design. [PDF]

Arch Cardiol Mex
Wyss F, Lopez-Santi R, Piskorz D, Gupta S, Munera-Echeverri A, Lopez-Santi P, Piskorz G, Ulluauri V, Gomez JE, Sueldo MD, Almonte C, Mendez M, Valdez O, Ponte-Negreti CI, Romero-Rivera I, Puente-Barragan A, Villar R, Effio J, Pichel D, Berrospi P, Barrientos AI, Silvera N, Jordan E, Dones W, Quezada D, Arguello A, Perez G, Baranchuk A.   +27 more
europepmc   +1 more source

Preliminary Case-Control Study of Antibody Response to Vaccines in Children on bDMARDs. [PDF]

Children (Basel)
Demirbuğa A, Dede E, Akgün Karapınar DB, Kaba Ö, Mete Atasever N, Durmuş MA, Önel M, Ağaçfidan A, Somer A, Hançerli Törün S.   +9 more
europepmc   +1 more source

Vaccinome Landscape in Nearly 620 000 Patients With Diabetes.

J Clin Endocrinol Metab
D'Addio F, Lazzaroni E, Lunati ME, Preziosi G, Ercolanoni M, Turola G, Marrocu C, Cicconi G, Sharma S, Scarioni S, Montefusco L, Pastore I, Morpurgo PS, Rossi A, Gandolfi A, Tinari C, Rossi G, Ben Nasr M, Loretelli C, Fiorina RM, Grassa B, Terranova R, Bucciarelli L, Berra C, Cereda D, Zuccotti G, Borriello CR, Fiorina P.   +27 more
europepmc   +1 more source

Attitudes toward and regional utilization of age-specific vaccinations from the age of 60 in Saxony-Anhalt. [PDF]

Res Health Serv Reg
Nestler S, Walter S, Hrudey I, Hasenpusch C, Holstiege J, Bätzing J, March S, Swart E, Stallmann C.   +8 more
europepmc   +1 more source

Safety and efficacy of eculizumab in pediatric patients with aHUS, with or without baseline dialysis [PDF]

, 2014
Bedrosian, Camille L, Greenbaum, Larry A, Kincaid, John F, Loirat, Chantal, Ogawa, Masayo, Vande Walle, Johan   +5 more
core   +1 more source

Machine learning-driven identification of serotype-independent pneumococcal vaccine candidates using samples from human infection challenge studies

Cheliotis KS, Gonzalez-Dias P, German EL, Gonçalves AN, Mitsi E, Nakaya HI, Nikolaou E, Pennington SH, Pojar S, Reiné J, Miyaji EN, Tostes R, Collins AM, Gordon SB, Pollard AJ, Lu Y, Malley R, Jochems SP, Urban B, Solórzano C, Ferreira DM.   +20 more
europepmc   +1 more source

Severe Invasive Pneumococcal Infection With Multiple Abscesses Caused by a Less Virulent Serotype 1 Pneumococcus: A Case Report. [PDF]

Cureus
Okuno T, Hamaguchi M, Yoshihiro A, Nakao M, Isobe T.   +4 more
europepmc   +1 more source

Contact with young children is a major risk factor for pneumococcal colonization in older adults. [PDF]

FEMS Microbes
Wyllie AL, Yolda-Carr D, Hislop MS, Mbodj S, Wurst L, Waghela P, Alexander-Parrish R, Grant LR, Arguedas A, Gessner BD, Weinberger DM.   +10 more
europepmc   +1 more source

The Complex Landscape of Updated Pneumococcal Conjugate Vaccines. [PDF]

Open Forum Infect Dis
Thindwa D, Shapiro ED, Weinberger DM.
europepmc   +1 more source